219 results
Page 4 of 11
8-K
EX-99.1
2hzpz87s7pt iyjwaj5
5 Aug 21
Madrigal Pharmaceuticals Reports 2021 Second Quarter Financial Results and Provides Corporate Update
8:31am
8-K
EX-1.1
b8mqd81bslws7wn6xmfv
1 Jun 21
Entry into a Material Definitive Agreement
8:01am
424B5
k2dfqqhmdq orrhv744
1 Jun 21
Prospectus supplement for primary offering
7:31am
8-K
EX-99.1
vjx76xlzxdy5rn
18 May 21
Alex Howarth Joins Madrigal Pharmaceuticals as Chief Financial Officer
8:30am
8-K
EX-99.1
bj5kbd10o
6 May 21
Madrigal Pharmaceuticals Reports 2021 First Quarter
8:31am
8-K
EX-99.1
nnn5tx
25 Feb 21
Madrigal Pharmaceuticals Reports 2020 Fourth Quarter
8:58am
424B5
mkvzyefk da
5 Nov 20
Prospectus supplement for primary offering
9:39am
8-K
EX-1.1
v8uzdx2
5 Nov 20
Entry into a Material Definitive Agreement
9:20am
8-K
EX-99.1
16t77cr96
5 Nov 20
Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter
8:52am
8-K
EX-99.1
3uhm bilecew25
6 Aug 20
Madrigal Pharmaceuticals Reports 2020 Second Quarter
8:50am
8-K
EX-99.1
bkg2 hi3w6ph0cu
7 May 20
Madrigal Pharmaceuticals Reports 2020 First Quarter
8:50am
8-K
EX-99.1
3k3k1gs8srk8a4p
26 Feb 20
Madrigal Pharmaceuticals Reports 2019 Fourth Quarter
8:50am